Imatinib for Restenosis Prevention - Imatinib for Restenosis Prevention

Description:

The goal of the trial was to evaluate the efficacy of treatment with imatinib, a platelet-derived growth factor (PDGF) receptor kinase inhibitor, compared with placebo among patients with in-stent restenosis (ISR).